BR112018015259A2 - métodos para preparação de anticorpos com um padrão de glicosilação definido - Google Patents
métodos para preparação de anticorpos com um padrão de glicosilação definidoInfo
- Publication number
- BR112018015259A2 BR112018015259A2 BR112018015259A BR112018015259A BR112018015259A2 BR 112018015259 A2 BR112018015259 A2 BR 112018015259A2 BR 112018015259 A BR112018015259 A BR 112018015259A BR 112018015259 A BR112018015259 A BR 112018015259A BR 112018015259 A2 BR112018015259 A2 BR 112018015259A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- molecules
- preparing antibodies
- antibodies
- defined glycosylation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Abstract
a presente descrição se relaciona com um processo para preparação de anticorpos com um padrão de glicosilação definido, em particular anticorpos com uma glicana terminando em uma n-acetilglucosamina. os anticorpos da descrição são adequados para uso em um processo para conjugar uma carga útil com eles. a descrição se estende também a moléculas obtidas e obteníveis a partir do processo descrito aqui, novas moléculas e intermediários, composições compreendendo as referidas moléculas e usos das moléculas e composições, particularmente em tratamento, por exemplo, no tratamento de câncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662287472P | 2016-01-27 | 2016-01-27 | |
PCT/US2017/015005 WO2017132298A1 (en) | 2016-01-27 | 2017-01-26 | Methods for preparing antibodies with a defined glycosylation pattern |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018015259A2 true BR112018015259A2 (pt) | 2018-12-18 |
Family
ID=59398609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018015259A BR112018015259A2 (pt) | 2016-01-27 | 2017-01-26 | métodos para preparação de anticorpos com um padrão de glicosilação definido |
Country Status (9)
Country | Link |
---|---|
US (1) | US11414477B2 (pt) |
EP (1) | EP3407914A4 (pt) |
JP (1) | JP6991978B2 (pt) |
CN (1) | CN108495653A (pt) |
AU (1) | AU2017212484C1 (pt) |
BR (1) | BR112018015259A2 (pt) |
CA (1) | CA3011734A1 (pt) |
RU (1) | RU2018128784A (pt) |
WO (1) | WO2017132298A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210030882A1 (en) * | 2018-03-30 | 2021-02-04 | Mitsui Chemicals, Inc. | Use of bis-iminobiotin compound for drug delivery purposes |
GB202116442D0 (en) * | 2021-11-15 | 2021-12-29 | Actome Gmbh | High-efficacy labeling of antibodies with oligonucleotide labels |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896111A (en) | 1973-02-20 | 1975-07-22 | Research Corp | Ansa macrolides |
US4151042A (en) | 1977-03-31 | 1979-04-24 | Takeda Chemical Industries, Ltd. | Method for producing maytansinol and its derivatives |
US4137230A (en) | 1977-11-14 | 1979-01-30 | Takeda Chemical Industries, Ltd. | Method for the production of maytansinoids |
US4307016A (en) | 1978-03-24 | 1981-12-22 | Takeda Chemical Industries, Ltd. | Demethyl maytansinoids |
US4265814A (en) | 1978-03-24 | 1981-05-05 | Takeda Chemical Industries | Matansinol 3-n-hexadecanoate |
JPS5562090A (en) | 1978-10-27 | 1980-05-10 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
JPS5566585A (en) | 1978-11-14 | 1980-05-20 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
JPS55164687A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
US4256746A (en) | 1978-11-14 | 1981-03-17 | Takeda Chemical Industries | Dechloromaytansinoids, their pharmaceutical compositions and method of use |
JPS55102583A (en) | 1979-01-31 | 1980-08-05 | Takeda Chem Ind Ltd | 20-acyloxy-20-demethylmaytansinoid compound |
JPS55162791A (en) | 1979-06-05 | 1980-12-18 | Takeda Chem Ind Ltd | Antibiotic c-15003pnd and its preparation |
JPS55164685A (en) | 1979-06-08 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
JPS55164686A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
US4309428A (en) | 1979-07-30 | 1982-01-05 | Takeda Chemical Industries, Ltd. | Maytansinoids |
JPS5645483A (en) | 1979-09-19 | 1981-04-25 | Takeda Chem Ind Ltd | C-15003phm and its preparation |
EP0028683A1 (en) | 1979-09-21 | 1981-05-20 | Takeda Chemical Industries, Ltd. | Antibiotic C-15003 PHO and production thereof |
JPS5645485A (en) | 1979-09-21 | 1981-04-25 | Takeda Chem Ind Ltd | Production of c-15003pnd |
WO1982001188A1 (en) | 1980-10-08 | 1982-04-15 | Takeda Chemical Industries Ltd | 4,5-deoxymaytansinoide compounds and process for preparing same |
US4450254A (en) | 1980-11-03 | 1984-05-22 | Standard Oil Company | Impact improvement of high nitrile resins |
US4313946A (en) | 1981-01-27 | 1982-02-02 | The United States Of America As Represented By The Secretary Of Agriculture | Chemotherapeutically active maytansinoids from Trewia nudiflora |
US4315929A (en) | 1981-01-27 | 1982-02-16 | The United States Of America As Represented By The Secretary Of Agriculture | Method of controlling the European corn borer with trewiasine |
JPS57192389A (en) | 1981-05-20 | 1982-11-26 | Takeda Chem Ind Ltd | Novel maytansinoid |
US5770701A (en) | 1987-10-30 | 1998-06-23 | American Cyanamid Company | Process for preparing targeted forms of methyltrithio antitumor agents |
US5606040A (en) | 1987-10-30 | 1997-02-25 | American Cyanamid Company | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
CA2026147C (en) | 1989-10-25 | 2006-02-07 | Ravi J. Chari | Cytotoxic agents comprising maytansinoids and their therapeutic use |
ZA932522B (en) | 1992-04-10 | 1993-12-20 | Res Dev Foundation | Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens |
US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
ATE300610T1 (de) | 1994-01-31 | 2005-08-15 | Univ Boston | Bibliotheken aus polyklonalen antikörpern |
US5773001A (en) | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
US5663149A (en) | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5714586A (en) | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
US5830912A (en) | 1996-11-15 | 1998-11-03 | Molecular Probes, Inc. | Derivatives of 6,8-difluoro-7-hydroxycoumarin |
ES2340112T3 (es) * | 1998-04-20 | 2010-05-28 | Glycart Biotechnology Ag | Ingenieria de glicosilacion de anticuerpos para la mejora de la citotoxicidad celular dependiente de anticuerpos. |
GB9818731D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
EP2322644A1 (en) * | 2000-06-28 | 2011-05-18 | GlycoFi, Inc. | Methods for producing modified glycoproteins |
CA2442801A1 (en) | 2001-04-02 | 2002-10-10 | Idec Pharmaceutical Corporation | Recombinant antibodies coexpressed with gntiii |
US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
EP2180044A1 (en) * | 2001-08-03 | 2010-04-28 | GlycArt Biotechnology AG | Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
US7776814B2 (en) | 2002-07-09 | 2010-08-17 | R&D-Biopharmaceuticals Gmbh | Tubulysin conjugates |
SI1523496T1 (sl) | 2002-07-18 | 2011-11-30 | Merus B V | Rekombinantno proizvajanje zmesi protiteles |
CA2510550A1 (en) | 2003-01-10 | 2004-07-29 | Pradman Qasba | Catalytic domains of .beta./1,4)-galactosyltransferase i having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use |
AU2004284075A1 (en) | 2003-10-22 | 2005-05-06 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
PT2270010E (pt) | 2004-03-01 | 2012-03-12 | Spirogen Ltd | Derivados de 11-hidroxi-5h-pirrolo[2,1-c][1,4]benzodiazepin- 5-ona como intermediários chave para a preparação de pirrolobenzodiazepinas substituídas em c2 |
GB0410725D0 (en) | 2004-05-13 | 2004-06-16 | Spirogen Ltd | Pyrrolobenzodiazepine therapeutic agents |
RU2451030C2 (ru) | 2004-10-26 | 2012-05-20 | Чугаи Сейяку Кабусики Кайся | Анти-глипикан 3-антитело, имеющее модифицированную сахарную цепь |
MX2007013039A (es) | 2005-04-21 | 2008-03-13 | Spirogen Ltd | Pirrolobenzodiazepinas. |
CN101370525B (zh) | 2005-08-19 | 2013-09-18 | Abbvie公司 | 双重可变结构域免疫球蛋白及其用途 |
US8637664B2 (en) | 2005-10-05 | 2014-01-28 | Spirogen Sarl | Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
CA2694488A1 (en) | 2007-07-31 | 2009-02-05 | Medimmune, Llc | Multispecific epitope binding proteins and uses thereof |
US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
WO2011036455A1 (en) | 2009-09-24 | 2011-03-31 | Ucb Pharma S.A. | Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes |
AU2010339309B2 (en) | 2009-12-28 | 2014-07-17 | Kyowa Hakko Kirin Co., Ltd. | Anti-IgA1 antibody |
GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
AU2011285532B2 (en) | 2010-08-06 | 2015-09-10 | Endocyte, Inc. | Processes for preparing tubulysins |
WO2013006544A1 (en) | 2011-07-06 | 2013-01-10 | Medimmune, Llc | Methods for making multimeric polypeptides |
ES2659155T3 (es) | 2011-07-13 | 2018-03-14 | Ucb Biopharma Sprl | Cepa hospedante bacteriana que expresa DSBC recombinante |
US9580509B2 (en) | 2011-11-07 | 2017-02-28 | Medimmune, Llc | Multispecific and multivalent binding proteins and uses thereof |
US9527927B2 (en) | 2011-12-20 | 2016-12-27 | Medimmune, Llc | Modified polypeptides for bispecific antibody scaffolds |
GB201201314D0 (en) * | 2012-01-26 | 2012-03-07 | Isis Innovation | Composition |
RS64329B1 (sr) * | 2012-10-23 | 2023-08-31 | Synaffix Bv | Modifikovano antitelo, konjugat antitela i postupak za njihovo pripremanje |
EP2935611B1 (en) * | 2013-10-14 | 2021-07-07 | SynAffix B.V. | Glycoengineered antibody, antibody-conjugate and methods for their preparation |
WO2015057065A1 (en) * | 2013-10-14 | 2015-04-23 | Synaffix B.V. | Glycoengineered antibody, antibody-conjugate and methods for their preparation |
-
2017
- 2017-01-26 US US16/072,982 patent/US11414477B2/en active Active
- 2017-01-26 JP JP2018538706A patent/JP6991978B2/ja active Active
- 2017-01-26 WO PCT/US2017/015005 patent/WO2017132298A1/en active Application Filing
- 2017-01-26 RU RU2018128784A patent/RU2018128784A/ru not_active Application Discontinuation
- 2017-01-26 CN CN201780008141.XA patent/CN108495653A/zh active Pending
- 2017-01-26 BR BR112018015259A patent/BR112018015259A2/pt not_active IP Right Cessation
- 2017-01-26 EP EP17744858.6A patent/EP3407914A4/en active Pending
- 2017-01-26 AU AU2017212484A patent/AU2017212484C1/en not_active Ceased
- 2017-01-26 CA CA3011734A patent/CA3011734A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2018128784A (ru) | 2020-02-27 |
AU2017212484B2 (en) | 2020-04-16 |
AU2017212484A1 (en) | 2018-08-09 |
CN108495653A (zh) | 2018-09-04 |
EP3407914A4 (en) | 2019-08-07 |
WO2017132298A1 (en) | 2017-08-03 |
JP6991978B2 (ja) | 2022-02-03 |
CA3011734A1 (en) | 2017-08-03 |
WO2017132298A8 (en) | 2018-07-12 |
JP2019506161A (ja) | 2019-03-07 |
AU2017212484C1 (en) | 2020-11-05 |
EP3407914A1 (en) | 2018-12-05 |
US20210214419A1 (en) | 2021-07-15 |
US11414477B2 (en) | 2022-08-16 |
RU2018128784A3 (pt) | 2020-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018012374A2 (es) | Moléculas de anticuerpo para el tratamiento del cáncer | |
BR112019007288A2 (pt) | proteína heterodimérica biespecífica, composições de ácido nucleico e de vetor de expressão, vetor de expressão, célula hospedeira, e, métodos para produzir proteína heterodimérica biespecífica e para tratar câncer em um paciente | |
BR112017008696A2 (pt) | métodos e composições para células exterminadoras naturais | |
CL2020003072A1 (es) | Moléculas de unión contra bcma y usos de las mismas | |
CO2018012415A2 (es) | Proteínas de unión específica y usos de las mismas | |
BR112017007093A2 (pt) | composições e métodos de uso para aumento da resposta imune e terapia do câncer | |
BR112016027585A2 (pt) | construções de anticorpo multiespecíficas | |
WO2019126634A3 (en) | Targeted integration of nucleic acids | |
BR112018074453A2 (pt) | proteínas de ligação biespecíficas ligando uma protéina imunomoduladora e um antígeno tumoral | |
MX2017006127A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
BR112016030424A2 (pt) | construções de anticorpo multiespecíficas | |
BR112017022488A2 (pt) | produção microbiana de terpenoides | |
BR112018013407A2 (pt) | anticorpos e conjugados dos mesmos | |
BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
BR112018000604A2 (pt) | moléculas de anticorpo que ligam cd45 | |
BR112017019412A2 (pt) | proteínas ligadoras de tslp | |
BR112017025322A2 (pt) | métodos integrados para tratamento de material lignocelulósico | |
BR112017005997A2 (pt) | método | |
CO2020004158A2 (es) | Composición de proteínas de guisante que tiene calidad nutricional mejorada | |
MX2018006386A (es) | Produccion de virus en evos aviares. | |
BR112017023391A2 (pt) | ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele? | |
BR112018010279A2 (pt) | novos anticorpos anti-emr2 e métodos de uso | |
UY37630A (es) | Combinación farmacéutica, kit, célula huésped que la produce y su uso en métodos para el tratamiento del cáncer | |
BR112018008670A2 (pt) | copolímero de propileno heterofásico, composição de poliolefina, artigo automotivo, processo para a preparação de uma composição de poliolefina, e, uso do copolímero de propileno heterofásico. | |
AR115695A1 (es) | Moléculas proteicas multifuncionales que comprenden decorina y uso de estas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2655 DE 23-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |